Regular use may help brighten skin tone, reduce pigmentation, and protect against oxidative stress, leading to healthier, clearer, and more youthful-looking skin.
In a move that could reshape how doctors approach both weight and heart health, the American College of Cardiology (ACC) released new guidance today recommending the use of popular weight-loss drugssuch as GLP-1 and GIP receptor agonistsas part of a strategy to reduce cardiovascular risk for those who are overweight
QUICK VERDICT Liposomal = slightly higher single-molecule absorption ceiling, but expensive and limited co-ingredient stacking
Zepbound was approved a year and a half later, in November 2023, for chronic weight management in adults with obesity as well as those who are overweight and have at least one weight-related condition (like high blood pressure or high cholesterol)
Real-world data shows that over half of patients on GLP-1 medications stop treatment within one year
The drug works because Semaglutide simulates a hormone called GLP-1 that regulates blood sugar levels
